Sona Nanotech Withdraws Health Canada Application For COVID-19 Test Due To Feedback From Regulator

In what is a major blow to shareholders of Sona Nanotech (CSE: SONA), the company this afternoon announced that it has withdrawn its rapid COVID-19 antigen application from Health Canada based on feedback it has received from the regulatory agency. The move is being conducted “in order to obtain more clinical data to augment its submission.”

While the application for approval has been withdrawn, the company indicate that it will “continue to pursue approval” of the test from the agency, which is a nasal swab-type test. Sona is also reportedly continuing to validate its saliva-based version of the rapid test. Now, the company will be looking to conduct a large scale trial for this saliva-based test.

Despite withdrawing its application for an interim order authorization from Health Canada for the marketing of its test, the company continued to state within the news release that it’s “COVID-19 antigen test offers results within 15 minutes.” The company also reiterated that testing has shown an agreement with RT-PCR tests 85% of the time, along with 96% sensitivity.

Cambria Gold Mines — sponsored Sponsored · Cambria Gold Mines

Commenting on the withdrawn application, President and chief scientific officer Darren Rowles stated, “The regulatory approval path for antigen tests is new with evolving guidelines and Sona’s test is unique, creating a challenging environment for test developers and regulators alike.” He then followed up that statement by indicating the company is committed to obtaining the data required.

A timeframe for the required data collection to proceed with Health Canada authorizations was not provided by the company. The company has indicated that it intends to resubmit its application as quickly as possible

Sona Nanotech last traded at $3.11 on the CSE.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Datametrex Conducts Over 23,700 COVID-19 Tests In Q4 Across Film Industry, Generating $4.0 Million In Revenue

Datametrex AI (TSXV: DM) this morning released data related to portions of its fourth quarter...

Tuesday, January 12, 2021, 07:11:37 AM

Hong Kong To Enforce Stricter Measures To Keep COVID-19 Patients At Home

COVID-19 patients quarantined at home in Hong Kong will soon be required to wear a...

Monday, July 11, 2022, 04:35:00 PM

Did Meta Just Admit to Censoring Americans?

Meta Platforms (Nasdaq: META) CEO Mark Zuckerberg has addressed concerns about government pressure on social...

Tuesday, August 27, 2024, 11:13:14 AM

China Protestors Have Zero Tolerance For China’s Zero COVID Policy

Beijing attempts to walk back on its stringent pandemic measures as uprising has been gaining...

Tuesday, November 29, 2022, 10:23:00 AM

Relay Medical Joint Venture Sees COVID-19 Device Launched In Rural Texas Hospitals

Relay Medical Corp (CSE: RELA) this morning announced that its joint venture with Fio Corp,...

Monday, November 23, 2020, 08:15:11 AM